Calydon, Inc. – Realized

NASDAQ: CEGE

Calydon, a gene therapy company focused on the development and commercialization of cancer vaccines and gene therapies to treat major, life-threatening diseases, was acquired by Cell Genesys, Inc. in September 2001.

www.cellgenesys.com